Filing Flows › Lantheus Holdings (LNTH) › Q2 2026 › vs Q2 2025
Lantheus Holdings (LNTH) Q2 2026 vs Q2 2025 (year over year)
Lantheus Holdings's revenue rose $10.1M (+3%) from $378M in Q2 2025 to $388M in Q2 2026. The biggest changes: Neuraceq +$39.6M (—); PYLARIFY −$10.3M (-4%); Strategic Partnerships and Other +$8.3M (+72%). Gross margin 62.3% against 63.8% (-1.4 pts).
Lantheus Holdings, Q2 2026: revenue $388M (+3% year over year), operating margin 25.8%, net earnings $75.0M, operating cash flow $92.2M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 62.3% | 63.8% | -1.4 pts |
| Operating margin | 25.8% | 23.3% | +2.5 pts |
| Net margin | 19.3% | 20.8% | -1.5 pts |
| Free cash flow margin | 23.2% | 20.9% | +2.2 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| PYLARIFY | $240M | $251M | −$10.3M | -4% |
| Definity | $88.3M | $83.9M | $4.3M | +5% |
| Neuraceq | $39.6M | $0 | $39.6M | — |
| Strategic Partnerships and Other | $19.9M | $11.6M | $8.3M | +72% |
| Revenue | $388M | $378M | $10.1M | +3% |
| Gross profit | $242M | $241M | $844K | +0.4% |
| Cost of revenue | $146M | $137M | $9.3M | +7% |
| Operating profit | $100M | $88.0M | $12.2M | +14% |
| Operating expenses | $142M | $153M | −$11.4M | -7% |
| Pre-tax earnings | $93.8M | $105M | −$10.7M | -10% |
| Other expense, net | $6.4M | −$16.6M | $22.9M | — |
| Research & development | $38.2M | $45.5M | −$7.3M | -16% |
| Sales & marketing | $82.8M | $41.0M | $41.8M | +102% |
| General & admin | $20.6M | $66.5M | −$45.9M | -69% |
| Net earnings | $75.0M | $78.8M | −$3.7M | -5% |
| Income tax | $18.8M | $25.8M | −$7.0M | -27% |
| Depreciation & amortization | $22.6M | $13.2M | $9.4M | +71% |
| Share-based compensation | $20.0M | $22.3M | −$2.3M | -10% |
| Working capital & other | $25.4M | $27.2M | −$1.8M | -7% |
| Operating cash flow | $92.2M | $87.1M | $5.1M | +6% |
| Free cash flow (company-reported) | $89.9M | $79.1M | $10.7M | +14% |
| Capital expenditures | $2.3M | $8.0M | −$5.6M | -71% |
Questions
How much did Lantheus Holdings's revenue grow year over year in Q2 2026?
Lantheus Holdings's revenue rose $10.1M (+3%) from $378M in Q2 2025 to $388M in Q2 2026.
What drove Lantheus Holdings's revenue change in Q2 2026?
Neuraceq +$39.6M (—); PYLARIFY −$10.3M (-4%); Strategic Partnerships and Other +$8.3M (+72%).